AWH - Aspira Women's Health Inc.
0.082
-0.012 -14.268%
Share volume: 4,742,494
Last Updated: 04-16-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.09
-0.01
-0.12%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-19-2024 | 03-27-2025 | 05-19-2025 | 08-12-2025 | 11-14-2025 | |
| Assets | ||||||||
| Total Assets | 7.164 M | 3.961 M | 4.759 M | 5.491 M | 6.716 M | 4.934 M | 7.296 M | |
| Current Assets | 6.122 M | 3.251 M | 4.113 M | 4.183 M | 5.391 M | 3.686 M | 5.825 M | |
| Inventories | 236.000 K | 226.000 K | 290.000 K | 326.000 K | 260.000 K | 273.000 K | 282.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.413 M | 962.000 K | 2.133 M | 1.769 M | 3.312 M | 1.545 M | 3.809 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 131.000 K | 120.000 K | 99.000 K | 69.000 K | 56.000 K | 44.000 K | 44.000 K | |
| Other Assets | 911.000 K | 590.000 K | 547.000 K | 1.239 M | 1.269 M | 1.204 M | 1.427 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 7.164 M | 3.961 M | 4.759 M | 5.491 M | 6.716 M | 4.934 M | 7.296 M | |
| Total liabilities | 8.527 M | 7.670 M | 7.279 M | 8.054 M | 6.776 M | 7.619 M | 11.640 M | |
| Total current liabilities | 5.293 M | 5.458 M | 5.466 M | 5.468 M | 3.791 M | 4.098 M | 4.199 M | |
| Accounts Payable | 1.643 M | 1.943 M | 2.551 M | 2.173 M | 1.451 M | 1.743 M | 1.811 M | |
| Other liabilities | 1.887 M | 948.000 K | 479.000 K | 1.308 M | 1.766 M | 2.361 M | 6.341 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.347 M | 1.264 M | 1.334 M | 1.278 M | 1.219 M | 1.160 M | 1.100 M | |
| Other liabilities | 1.887 M | 948.000 K | 479.000 K | 1.308 M | 1.766 M | 2.361 M | 6.341 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.363 M | -3.709 M | -2.520 M | -2.563 M | -60.000 K | -2.685 M | -4.344 M | |
| Common stock | 521.569 M | 522.753 M | 527.489 M | 528.834 M | 533.190 M | 533.231 M | 536.464 M | |
| Retained earnings | -522.932 M | -526.462 M | 0.000 | 0.000 | 0.000 | 0.000 | -540.808 M |